business

Novo Stock Rises After Earnings. It’s Taking the Weight-Loss Drug Fight to Eli Lilly.

Yahoo Finance · May 6, 2026, 10:12 AM · Also reported by 4 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

MarketWatch Novo Nordisk says the Wegovy pill saw the fastest take-up in weight-loss drug history. Investing.com Snap stock rating held at Sector Weight by KeyBanc ahead of earnings Investing.com Earnings call transcript: Diageo Q3 2026 shows mixed performance, stock rises Financial Times Novo Nordisk lifts forecasts after strong demand for Wegovy weight-loss pill

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Novo Stock Rises After Earnings. It’s Taking the Weight-Loss Drug Fight to Eli Lilly.

Also covered by

More in business